FENC financials
Fennec Pharmaceuticals (FENC) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
FENC income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $44.64M | – | -$6.28M | -$9.74M | -0.34 |
| 2024 | $47.54M | – | $2.57M | -$436.00K | -0.02 |
| 2023 | $21.25M | $19.99M | -$12.77M | -$16.05M | -0.60 |
| 2022 | $1.53M | $1.45M | -$22.59M | -$23.71M | -0.90 |
| 2021 | – | – | -$17.22M | -$17.35M | -0.67 |
| 2020 | $170.00K | – | -$17.89M | -$18.11M | -0.76 |
- FENC revenue was $44.64M in fiscal 2025, net income -$9.74M.
Updated 2026-11-17 17:46 UTC